tofacitinib and Esophageal-Diseases

tofacitinib has been researched along with Esophageal-Diseases* in 1 studies

Other Studies

1 other study(ies) available for tofacitinib and Esophageal-Diseases

ArticleYear
Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis.
    Clinical journal of gastroenterology, 2020, Volume: 13, Issue:3

    A 26-year-old man was admitted to our institution for ulcerative colitis treatment. He used mesalamine, steroid, immunomodulators, and anti-TNFα anti-body, but it was difficult to maintain remission. We started induction therapy with tofacitinib (TOF) 10 mg twice daily. He maintained clinical remission but had chest pain 44 days after the start of TOF. Esophagogastroduodenoscopy showed multiple ulcers from middle to lower esophagus. Although rare, TOF induced esophageal ulcers were considered based on his clinical course and endoscopic findings.

    Topics: Adult; Colitis, Ulcerative; Esophageal Diseases; Esophagoscopy; Esophagus; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Ulcer

2020